NF1 MUTATION
Clinical trials for NF1 MUTATION explained in plain language.
Never miss a new study
Get alerted when new NF1 MUTATION trials appear
Sign up with your email to follow new studies for NF1 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets tough cancers: early trial seeks safer doses
Disease control Recruiting nowThis early-phase study tests an experimental drug called PAS-004 in about 48 adults with advanced solid tumors that have certain gene mutations (RAS, NF1, or RAF). The main goal is to find a safe dose and understand side effects. Participants take the drug by mouth daily for up t…
Matched conditions: NF1 MUTATION
Phase: PHASE1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
New pill could shrink nerve tumors in NF1 patients
Disease control Recruiting nowThis early-stage trial tests an experimental drug called PAS-004 in adults with neurofibromatosis type 1 (NF1) who have at least one symptomatic, inoperable nerve tumor (plexiform neurofibroma). The study aims to find safe doses and check for side effects. Participants take a dai…
Matched conditions: NF1 MUTATION
Phase: PHASE1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
New stem cell method may cut transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests a new way to prepare donor stem cells for transplant in people with blood cancers like leukemia. By removing certain immune cells from the donated cells, researchers hope to lower the risk of graft-versus-host disease, a serious side effect. The study involves 70…
Matched conditions: NF1 MUTATION
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 08:27 UTC